Zhou Y - Search Results

1

Prediction of Overall Survival and Progression-Free Survival by the ¹⁸F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.

Zhou Y, Ma XL, Pu LT, Zhou RF, Ou XJ, Tian R. Zhou Y, et al. Among authors: zhou rf. Contrast Media Mol Imaging. 2019 Oct 30;2019:5963607. doi: 10.1155/2019/5963607. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 31777473 Free PMC article.

2

Ability of ¹⁸F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma.

Ou X, Wang J, Zhou R, Zhu S, Pang F, Zhou Y, Tian R, Ma X. Ou X, et al. Among authors: zhou y, zhou r. Contrast Media Mol Imaging. 2019 Feb 25;2019:4507694. doi: 10.1155/2019/4507694. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 30930700 Free PMC article.

3

Solitary Bone Langerhans Cell Histiocytosis Demonstrated on Multimodality Imaging in an Adult.

Zhao Y, Zhou Y, Tian R, Su M. Zhao Y, et al. Among authors: zhou y. Clin Nucl Med. 2020 Jan;45(1):78-80. doi: 10.1097/RLU.0000000000002845. Clin Nucl Med. 2020. PMID: 31789916

4

Gastric 99mTc-Methylene Diphosphonate Accumulation in a Patient With Primary Upper Gastrointestinal Tract Melanoma.

Zhou Y, Fan QP, Tian R, Su MG. Zhou Y, et al. Clin Nucl Med. 2020 Feb;45(2):164-167. doi: 10.1097/RLU.0000000000002855. Clin Nucl Med. 2020. PMID: 31833932

5

Current status and quality of radiomics studies in lymphoma: a systematic review.

Wang H, Zhou Y, Li L, Hou W, Ma X, Tian R. Wang H, et al. Among authors: zhou y. Eur Radiol. 2020 Nov;30(11):6228-6240. doi: 10.1007/s00330-020-06927-1. Epub 2020 May 29. Eur Radiol. 2020. PMID: 32472274

6

Use of radiomics based on ¹⁸F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach.

Zhou Y, Ma XL, Zhang T, Wang J, Zhang T, Tian R. Zhou Y, et al. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2904-2913. doi: 10.1007/s00259-021-05220-7. Epub 2021 Feb 5. Eur J Nucl Med Mol Imaging. 2021. PMID: 33547553

7

Heterogeneous Uptake of 68 Ga-DOTATATE and 18 F-FDG in Initial Diagnosed Neuroendocrine Tumors Patients : Which Patients Are Suitable for Dual-Tracer PET Imaging?

Zhou Y, Li L, Wang H, Huang HX, Cao D, Ke NW, Su MG, Tian R. Zhou Y, et al. Clin Nucl Med. 2024 Jun 1;49(6):516-520. doi: 10.1097/RLU.0000000000005231. Epub 2024 Apr 19. Clin Nucl Med. 2024. PMID: 38637950

8

Radiomics based on ¹⁸F-FDG PET for predicting treatment response and prognosis in newly diagnosed diffuse large B-cell lymphoma patients: do lesion selection and segmentation methods matter?

Zhou Y, Zhou XY, Xu YC, Ma XL, Tian R. Zhou Y, et al. Among authors: zhou xy. Quant Imaging Med Surg. 2025 Jan 2;15(1):103-120. doi: 10.21037/qims-24-585. Epub 2024 Dec 30. Quant Imaging Med Surg. 2025. PMID: 39839002 Free PMC article.

9

Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.

Wen F, Tang R, Sang Y, Li M, Hu Q, Du Z, Zhou Y, Zhang P, He X, Li Q. Wen F, et al. Among authors: zhou y. Cancer Sci. 2013 Oct;104(10):1330-8. doi: 10.1111/cas.12224. Epub 2013 Jul 30. Cancer Sci. 2013. PMID: 23822592 Free PMC article.

10

First-line irinotecan combined with 5-fluorouracil and leucovorin for high-grade metastatic gastrointestinal neuroendocrine carcinoma.

Du Z, Wang Y, Zhou Y, Wen F, Li Q. Du Z, et al. Among authors: zhou y. Tumori. 2013 Jan-Feb;99(1):57-60. doi: 10.1177/030089161309900110. Tumori. 2013. PMID: 23549001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,804 results

Search Page

Filters